(Q41346456)

29 September 2017

title

Positive and negative syndromes in schizophrenia as a function of chronicity (English)

1 reference

29 September 2017

1 reference

Kay SR

1 reference

29 September 2017

Fiszbein A

series ordinal

1 reference

29 September 2017

Lindenmayer JP

series ordinal

1 reference

29 September 2017

Opler LA

series ordinal

1 reference

29 September 2017

language of work or name

English

0 references

publication date

1 November 1986

1 reference

Acta Psychiatrica Scandinavica

29 September 2017

published in

1 reference

29 September 2017

1 reference

29 September 2017

1 reference

29 September 2017

page(s)

507-518

1 reference

Negative v positive schizophrenia. Definition and validation

29 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

Symptomatic and neuropsychological components of defect states

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

Treatment of negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

Positive vs. negative schizophrenia: a critical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

The two-syndrome concept: origins and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

Negative and positive symptoms in schizophrenia and depression: a followup

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

Negative symptoms in schizophrenia: their longitudinal course and prognostic importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

Negative symptoms in schizophrenia. Definition and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

A comparative study of haloperidol and chlorpromazine in terms of clinical effects and therapeutic reversal with benztropine in schizophrenia. Theoretical implications for potency differences among neuroleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

'Akinetic Depression' in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

The prediction of outcome in schizophrenia. II. Relationships between predictor and outcome variables: a report from the WHO international pilot study of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

Positive and negative schizophrenic symptoms, attention, and information processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

21 January 2018

Components of attention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.1986.TB06276.X

10.1111/J.1600-0447.1986.TB06276.X

21 January 2018

Identifiers

DOI

1 reference

29 September 2017

1 reference